The Trial (Part II) review at The Rose Lipman Building London
Part II of Retz theatre company’s reimagining of Franz Kafka’s The Trial in London’s East End has each person in the audience implicated for a crime in the future based on what they may or may not do.
Once again it would be a spoiler to reveal what happens. Retz has taken over the Rose Lipman Building in a sleepy street in Dalston. The transformation is impeccable. The tense paranoia of Kafka’s nightmare plays out through a series of dusty rooms as a huge cast feathers a file of your ‘history’ – each room more unsettling than the last – until you are found guilty for your online behaviour.
What strikes deepest here is the actors’ ability to stay true, person after person, essentially improvising for everyone as they roll through the doors. It matters that it’s so good, because with any immersive theatre project, convincing the naysayers to get involved must be heartburn for the team. But, Retz stands out – the attention to detail, the control, and more than anything else the set, which is outstanding, grips from first to last.
Here is a project in the East End that justifies its weighty funding.
The Rose Lipman Building, London, April 2-27
- Franz Kafka, Joshua Nawras/Felix Mortimer (adaptation)
- Felix Mortimer
- Daisy Cooper, Felix Mortimer, Joshua Nawras
- Cast includes
- Ewan Benfield, Bill Bingham, Josie Bloom, Victoria Broom, Olivette Cole Wilson, Sam Dent, Silvanna Maimone, Nic Lamont, Myles Nichol, Igor Belache
- Running time
We need your help…
When you subscribe to The Stage, you’re investing in our journalism. And our journalism is invested in supporting theatre and the performing arts.
The Stage is a family business, operated by the same family since we were founded in 1880. We do not receive government funding. We are not owned by a large corporation. Our editorial is not dictated by ticket sales.
We are fully independent, but this means we rely on revenue from readers to survive.
Help us continue to report on great work across the UK, champion new talent and keep up our investigative journalism that holds the powerful to account. Your subscription helps ensure our journalism can continue.